218 related articles for article (PubMed ID: 8365932)
1. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol.
Russell AH; Clyde C; Wasserman TH; Turner SS; Rotman M
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):117-23. PubMed ID: 8365932
[TBL] [Abstract][Full Text] [Related]
2. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer.
Mohiuddin M; Chen E; Ahmad N
J Clin Oncol; 1996 Mar; 14(3):722-8. PubMed ID: 8622017
[TBL] [Abstract][Full Text] [Related]
3. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
Folkert MR; Meyer JJ; Aguilera TA; Yokoo T; Sanford NN; Rule WG; Mansour J; Yopp A; Polanco P; Hannan R; Nedzi LA; Timmerman RD
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1387-1395. PubMed ID: 33340601
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial.
Wu KL; Jiang GL; Liao Y; Qian H; Wang LJ; Fu XL; Zhao S
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1336-44. PubMed ID: 14630271
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
7. 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study.
Stillwagon GB; Order SE; Guse C; Klein JL; Leichner PK; Leibel SA; Fishman EK
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1223-9. PubMed ID: 2557307
[TBL] [Abstract][Full Text] [Related]
8. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
Robertson JM; McGinn CJ; Walker S; Marx MV; Kessler ML; Ensminger WD; Lawrence TS
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1087-92. PubMed ID: 9392548
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
10. A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases--RTOG 88-22.
Scarantino CW; Caplan R; Rotman M; Coughlin C; Demas W; Delrowe J
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):37-48. PubMed ID: 8823257
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
12. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
Fu KK; Pajak TF; Marcial VA; Ortiz HG; Rotman M; Asbell SO; Coia LR; Vora NL; Byhardt R; Rubin P
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):577-88. PubMed ID: 7790242
[TBL] [Abstract][Full Text] [Related]
13. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28.
Epstein BE; Scott CB; Sause WT; Rotman M; Sneed PK; Janjan NA; Davis LW; Selim H; Mohiuddin M; Wasserman TH
Cancer; 1993 Feb; 71(4):1362-7. PubMed ID: 8435812
[TBL] [Abstract][Full Text] [Related]
14. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372
[TBL] [Abstract][Full Text] [Related]
15. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapy.
Barry A; McPartlin A; Lindsay P; Wang L; Brierley J; Kim J; Ringash J; Wong R; Dinniwell R; Craig T; Dawson LA
Pract Radiat Oncol; 2017; 7(5):e331-e337. PubMed ID: 28442242
[TBL] [Abstract][Full Text] [Related]
17. Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases.
Shilkrut M; Sapir E; Hanasoge S; Schipper MJ; Normolle DP; Ben-Josef E; Ensminger W; Lawrence TS; Feng M
Am J Clin Oncol; 2018 Apr; 41(4):326-331. PubMed ID: 26886946
[TBL] [Abstract][Full Text] [Related]
18. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
19. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy.
Robertson JM; Lawrence TS; Walker S; Kessler ML; Andrews JC; Ensminger WD
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):445-50. PubMed ID: 7751185
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine.
Lawrence TS; Dworzanin LM; Walker-Andrews SC; Andrews JC; Ten Haken RK; Wollner IS; Lichter AS; Ensminger WD
Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):555-61. PubMed ID: 1847363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
